Adlai Nortye Biopharma Co., Ltd.
Clinical trials sponsored by Adlai Nortye Biopharma Co., Ltd., explained in plain language.
-
New cancer drug AN4005 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called AN4005 in about 31 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Participants receive the drug and are closely monitored …
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Recruiting nowThis early-phase study tests a new daily pill, AN9025, in people with advanced solid tumors that have specific RAS gene mutations. The main goals are to check the drug's safety and find the right dose. About 91 adults will take the drug daily and visit the clinic regularly for mo…
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC